Firsthand Technology Value Fund Inc is an externally managed, non-diversified, closed-end management investment company. The Fund's investment objective is to seek long-term growth of capital, principally by seeking capital gains on its equity and equity-related investments. Its portfolio is primarily composed of equity and equity derivative securities of technology and cleantech companies. Its primary focus is to invest in illiquid private technology and cleantech companies. It may also invest in micro-cap publicly traded companies.
AEterna Zentaris Inc is a specialty biopharmaceutical company. It is involved in the development and commercialization of novel pharmaceutical therapies, drug development activities and promotion of products for others in oncology, endocrinology and women's health. The company focuses on the acquisition of licenses to products that are relevant to their therapeutic areas of focus. Its primary product is Apifiny. It is developing Macrilen, Zoptrex and AEZS drugs in the pipeline. https://www.zentaris.com/